85 related articles for article (PubMed ID: 35444193)
21. Comparative Study of Amide Proton Transfer Imaging and Intravoxel Incoherent Motion Imaging for Predicting Histologic Grade of Hepatocellular Carcinoma.
Wu B; Jia F; Li X; Li L; Wang K; Han D
Front Oncol; 2020; 10():562049. PubMed ID: 33194630
[No Abstract] [Full Text] [Related]
22. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging.
Chen W; Li L; Yan Z; Hu S; Feng J; Liu G; Liu B; Liu X
Eur Radiol; 2021 May; 31(5):3286-3296. PubMed ID: 33125558
[TBL] [Abstract][Full Text] [Related]
23. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
[TBL] [Abstract][Full Text] [Related]
24. Perfusion-driven Intravoxel Incoherent Motion (IVIM) MRI in Oncology: Applications, Challenges, and Future Trends.
Iima M
Magn Reson Med Sci; 2021 Jun; 20(2):125-138. PubMed ID: 32536681
[TBL] [Abstract][Full Text] [Related]
25. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
Li L; Chen W; Yan Z; Feng J; Hu S; Liu B; Liu X
J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
[TBL] [Abstract][Full Text] [Related]
26. Quantitative assessment of Ki67 expression in correlation with various breast cancer characteristics and survival rate; cross sectional study.
Mohammed AA
Ann Med Surg (Lond); 2019 Dec; 48():129-134. PubMed ID: 31788239
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging of mean cell size in human breast tumors.
Xu J; Jiang X; Li H; Arlinghaus LR; McKinley ET; Devan SP; Hardy BM; Xie J; Kang H; Chakravarthy AB; Gore JC
Magn Reson Med; 2020 Jun; 83(6):2002-2014. PubMed ID: 31765494
[TBL] [Abstract][Full Text] [Related]
28. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
[TBL] [Abstract][Full Text] [Related]
29. Diffusion MRI of the breast: Current status and future directions.
Iima M; Honda M; Sigmund EE; Ohno Kishimoto A; Kataoka M; Togashi K
J Magn Reson Imaging; 2020 Jul; 52(1):70-90. PubMed ID: 31520518
[TBL] [Abstract][Full Text] [Related]
30. Comparison of pulsed and oscillating gradient diffusion-weighted MRI for characterizing hepatocellular nodules in liver cirrhosis: ex vivo study in a rat model.
Wagner M; Doblas S; Poté N; Lambert SA; Ronot M; Garteiser P; Paradis V; Vilgrain V; Van Beers BE
J Magn Reson Imaging; 2020 Apr; 51(4):1065-1074. PubMed ID: 31507025
[TBL] [Abstract][Full Text] [Related]
31. The utility of APT and IVIM in the diagnosis and differentiation of squamous cell carcinoma of the cervix: A pilot study.
Li B; Sun H; Zhang S; Wang X; Guo Q
Magn Reson Imaging; 2019 Nov; 63():105-113. PubMed ID: 31425797
[TBL] [Abstract][Full Text] [Related]
32. 7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer.
Zaric O; Farr A; Poblador Rodriguez E; Mlynarik V; Bogner W; Gruber S; Asseryanis E; Singer CF; Trattnig S
Magn Reson Imaging; 2019 Jun; 59():77-87. PubMed ID: 30880110
[TBL] [Abstract][Full Text] [Related]
33. How clinical imaging can assess cancer biology.
García-Figueiras R; Baleato-González S; Padhani AR; Luna-Alcalá A; Vallejo-Casas JA; Sala E; Vilanova JC; Koh DM; Herranz-Carnero M; Vargas HA
Insights Imaging; 2019 Mar; 10(1):28. PubMed ID: 30830470
[TBL] [Abstract][Full Text] [Related]
34. Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors.
Iima M; Yamamoto A; Kataoka M; Yamada Y; Omori K; Feiweier T; Togashi K
J Magn Reson Imaging; 2019 Jul; 50(1):88-95. PubMed ID: 30578563
[TBL] [Abstract][Full Text] [Related]
35. Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions.
Kamimura K; Nakajo M; Yoneyama T; Takumi K; Kumagae Y; Fukukura Y; Yoshiura T
Jpn J Radiol; 2019 Feb; 37(2):109-116. PubMed ID: 30341472
[TBL] [Abstract][Full Text] [Related]
36. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
37. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
38. Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T.
Klein J; Lam WW; Czarnota GJ; Stanisz GJ
Oncotarget; 2018 Jul; 9(59):31490-31501. PubMed ID: 30140385
[TBL] [Abstract][Full Text] [Related]
39. Assessments of tumor metabolism with CEST MRI.
Goldenberg JM; Pagel MD
NMR Biomed; 2019 Oct; 32(10):e3943. PubMed ID: 29938857
[TBL] [Abstract][Full Text] [Related]
40. Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis.
Surov A; Clauser P; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Meyer HJ; Wienke A
Breast Cancer Res; 2018 Jun; 20(1):58. PubMed ID: 29921323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
